Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma.
Carpentier A, Laigle-Donadey F, Zohar S, Capelle L, Behin A, Tibi A, Martin-Duverneuil N, Sanson M, Lacomblez L, Taillibert S, Puybasset L, Van Effenterre R, Delattre JY, Carpentier AF.
Carpentier A, et al.
Neuro Oncol. 2006 Jan;8(1):60-6. doi: 10.1215/S1522851705000475.
Neuro Oncol. 2006.
PMID: 16443949
Free PMC article.
Clinical Trial.